AstraZeneca says it takes China investigation ‘very seriously’
UK’s biggest pharmaceutical company ‘committed to China’ as it raises 2024 profit forecast and announces $3.5bn US investment
AstraZeneca’s chief executive has said it is taking investigations by Chinese authorities into its business in the country “very seriously” and insisted it is committed to China in the long run.
Authorities are thought to be investigating the importation of two cancer treatments manufactured by Britain’s biggest pharmaceutical company into China.
Continue reading...
Read more at The Guardian
-
AstraZeneca embarks on major US expansion
Business - Financial Times - November 12 -
UK borrowing costs rise as Reeves’ spending plans unnerve investors
Business - Financial Times - October 30 -
AstraZeneca China president under investigation by Chinese authorities
Business - Financial Times - October 30 -
PGMOL taking new Coote allegations 'very seriously'
Top stories - BBC News - November 13
More from The Guardian
-
Netanyahu says ICC warrant for his arrest over alleged war crimes is ‘antisemitic’ and ‘absurd’ – Middle East live
World - The Guardian - 22 minutes ago -
Ukraine claims Russia fired intercontinental ballistic missile at Dnipro
World - The Guardian - 1 hour ago -
Police report details sexual assault allegations against Pete Hegseth
World - The Guardian - 50 minutes ago -
Transgender woman wins record payout in China after electroshock treatment
World - The Guardian - 4 hours ago -
John Prescott, British former deputy prime minister, dies aged 86
World - The Guardian - 5 hours ago